{
    "id": "clinical_knowledge-021",
    "question": "If a transfusion reaction is suspected, you should:",
    "options": {
        "A": "turn off the transfusion, inform medical staff immediately, and follow transfusion policy advice on dealing with acute transfusion reactions.",
        "B": "leave the transfusion running and contact the medical staff immediately.",
        "C": "disconnect and dispose of the blood bag immediately.",
        "D": "leave the transfusion running and record a set of observations on the patient."
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine the correct course of action when a transfusion reaction is suspected, it is essential to follow established protocols to ensure the patient's safety. The first step is to immediately stop the transfusion to prevent further exposure to the suspected allergen or pathogen. This is crucial to prevent any potential harm to the patient. The next step is to inform medical staff immediately to alert them to the situation and initiate the necessary procedures. Following this, it is essential to follow the transfusion policy advice on dealing with acute transfusion reactions, which may include administering medications, monitoring the patient's vital signs, and preparing for potential complications. The options provided in the question do not include the step of stopping the transfusion and informing medical staff, which is a critical initial action. Options B, D, and C may be part of the subsequent steps, but they do not address the immediate need to stop the transfusion and alert medical staff. Therefore, the correct answer is not explicitly listed, but the closest correct action is option A, with the addition of stopping the transfusion and informing medical staff immediately. However, based on the options provided, the closest correct answer is A, with the understanding that it should be modified to include stopping the transfusion and informing medical staff immediately.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_9017",
            "title": "InternalMed_Harrison",
            "content": "Abbreviations: FNHTR, febrile nonhemolytic transfusion reaction; HTLV, human T lymphotropic virus; RBC, red blood cell; TRALI, transfusion-related acute lung injury. the patient\u2019s vital signs before and during the transfusion is important to identify reactions promptly. When acute hemolysis is suspected, the transfusion must be stopped immediately, intravenous access maintained, and the reaction reported to the blood bank. A correctly labeled posttransfusion blood sample and any untransfused blood should be sent to the blood bank for analysis. The laboratory evaluation for hemolysis includes the measurement of serum haptoglobin, lactate dehydrogenase (LDH), and indirect bilirubin levels."
        },
        {
            "id": "First_Aid_Step2_392",
            "title": "First_Aid_Step2",
            "content": "Nonhemolytic febrile reactions: Involve cytokine formation during the storage of blood, and WBC antibodies. Minor allergic reactions: Involve antibody formation (usually IgA) against donor proteins. Usually occur following transfusion of plasma-containing product. Hemolytic transfusion reactions: Entail the development of antibodies against donor erythrocytes. Usually result from ABO incompatibility or from antibody against minor antigens. Nonhemolytic febrile reactions: Present with fever, chills, rigors, and malaise. Symptom onset is 1\u20136 hours following transfusion. Minor allergic reactions: Characterized by urticaria. Hemolytic transfusion reactions: Present with fever, chills, nausea, \ufb02 ushing, apprehension, back pain, burning at the IV site, tachycardia, tachypnea, and hypotension. Symptoms begin following the transfusion of only a small amount of blood. Diagnosed by clinical impression."
        },
        {
            "id": "InternalMed_Harrison_9014",
            "title": "InternalMed_Harrison",
            "content": "Adverse reactions to transfused blood components occur despite multiple tests, inspections, and checks. Fortunately, the most common reactions are not life threatening, although serious reactions can present with mild symptoms and signs. Some reactions can be reduced or prevented by modified (filtered, washed, or irradiated) blood components. When an adverse reaction is suspected, the transfusion should be stopped and reported to the blood bank for investigation. Transfusion reactions may result from immune and nonimmune mechanisms. Immune-mediated reactions are often due to preformed donor or recipient antibody; however, cellular elements may also cause adverse effects. Nonimmune causes of reactions are due to the chemical and physical properties of the stored blood component and its additives."
        },
        {
            "id": "Surgery_Schwartz_870",
            "title": "Surgery_Schwartz",
            "content": "reaction. The first sign of a transfusion reaction may be diffuse bleeding. The pathogenesis of this bleed-ing is thought to be related to the release of ADP from hemolyzed red blood cells, resulting in diffuse platelet aggregation, after which the platelet clumps are removed out of the circulation.Transfusion purpura occurs when the donor platelets are of the uncommon HPA-1 group. This is an uncommon cause of thrombocytopenia and associated bleeding after transfusion. The platelets sensitize the recipient, who makes antibody to the foreign platelet antigen. The foreign platelet antigen does not completely disappear from the recipient circulation but attaches to the recipient\u2019s own platelets. The antibody then destroys the recipient\u2019s own platelets. The resultant thrombocytopenia and bleeding may continue for several weeks. This uncommon cause of thrombocytopenia should be considered if bleeding follows transfusion by 5 or 6 days. Platelet transfusions are of little help in the"
        },
        {
            "id": "Surgery_Schwartz_842",
            "title": "Surgery_Schwartz",
            "content": "and death in up 25% of patients.151 Clinical manifesta-tions includes systemic signs such as fever and chills, tachycar-dia and hypotension, and gastrointestinal symptoms (abdominal cramps, vomiting, and diarrhea). If the diagnosis is suspected, the transfusion should be discontinued and the blood cultured. Emergency treatment includes oxygen, adrenergic blocking agents, and antibiotics.Allergic Reactions. Allergic reactions are relatively frequent, occurring in about 1% of all transfusions. Reactions are usually mild and consist of rash, urticaria, and flushing. In rare instances, anaphylactic shock develops. Allergic reactions are caused by the transfusion of antibodies from hypersensitive donors or the trans-fusion of antigens to which the recipient is hypersensitive. Allergic reactions can occur after the administration of any blood product but are commonly associated with FFP and platelets. Treatment and prophylaxis consist of the administration of antihistamines. In more serious"
        },
        {
            "id": "Surgery_Schwartz_2872",
            "title": "Surgery_Schwartz",
            "content": "select patients, the decision to transfuse should gener-ally not occur until the hemoglobin level falls to 7 mg/dL or the hematocrit reaches 21%.Transfusion reactions are common complications of blood transfusion. These can be attenuated with a leukocyte filter, but not completely prevented. The manifestations of a transfusion reaction include simple fever, pruritus, chills, muscle rigidity, and renal failure due to myoglobinuria secondary to hemolysis. Discontinuing the transfusion and returning the blood products to the blood bank is an important first step, but administration of antihistamine and possibly steroids may be required to control the reaction symptoms. Severe transfusion reactions are rare but can be fatal.Infectious complications in blood transfusion range from cytomegalovirus transmission, which is benign in the nontrans-plant patient, to human immunodeficiency virus (HIV) infec-tion, to passage of the hepatitis viruses (Table 12-16).Patients on warfarin (Coumadin) who"
        },
        {
            "id": "InternalMed_Harrison_9019",
            "title": "InternalMed_Harrison",
            "content": "Errors at the patient\u2019s bedside, such as mislabeling the sample or transfusing the wrong patient, are responsible for the majority of these reactions. The blood bank investigation of these reactions includes examination of the preand posttransfusion samples for hemolysis and repeat typing of the patient samples; direct antiglobulin test (DAT), sometimes called the direct Coombs test, of the posttransfusion sample; repeating the cross-matching of the blood component; and checking all clerical records for errors. DAT detects the presence of antibody or complement bound to RBCs in vivo (Fig. 138e-1). Delayed Hemolytic and Serologic Transfusion Reactions Delayed hemolytic transfusion reactions (DHTRs) are not completely preventable."
        },
        {
            "id": "Surgery_Schwartz_851",
            "title": "Surgery_Schwartz",
            "content": "resulting in tubu-lar necrosis and precipitation of hemoglobin within the tubules.Delayed hemolytic transfusion reactions occur 2 to 10 days after transfusion and are characterized by extravascular hemolysis, mild anemia, and indirect (unconjugated) hyperbili-rubinemia. They occur when an individual has a low antibody titer at the time of transfusion, but the titer increases after trans-fusion as a result of an anamnestic response. Reactions to non-ABO antigens involve immunoglobulin G-mediated clearance by the reticuloendothelial system.If the patient is awake, the most common symptoms of acute transfusion reactions are pain at the site of transfusion, facial flushing, and back and chest pain. Associated symptoms include fever, respiratory distress, hypotension, and tachycardia. In anesthetized patients, diffuse bleeding and hypotension are the hallmarks. A high index of suspicion is needed to make the diag-nosis. The laboratory criteria for a transfusion reaction are"
        },
        {
            "id": "InternalMed_Harrison_9044",
            "title": "InternalMed_Harrison",
            "content": "Recipients of transfusion contaminated with bacteria may develop fever and chills, which can progress to septic shock and DIC. These reactions may occur abruptly, within minutes of initiating the transfusion, or after several hours. The onset of symptoms and signs is often sudden and fulminant, which distinguishes bacterial contamination from an FNHTR. The reactions, particularly those related to gram-negative contaminants, are the result of infused endotoxins formed within the contaminated stored component. When these reactions are suspected, the transfusion must be stopped immediately. Therapy is directed at reversing any signs of shock, and broad-spectrum antibiotics should be given. The blood bank should be notified to identify any clerical or serologic error. The blood component bag should be sent for culture and Gram stain."
        },
        {
            "id": "InternalMed_Harrison_9020",
            "title": "InternalMed_Harrison",
            "content": "Delayed Hemolytic and Serologic Transfusion Reactions Delayed hemolytic transfusion reactions (DHTRs) are not completely preventable. These reactions occur in patients previously sensitized to RBC alloantigens who have a negative alloantibody screen due to low antibody levels. When the patient is transfused with antigen-positive blood, an anamnestic response results in the early production of alloantibody that binds donor RBCs. The alloantibody is detectable 1\u20132 weeks following the transfusion, and the posttransfusion DAT may become positive due to circulating donor RBCs coated with antibody or complement. The transfused, alloantibody-coated erythrocytes are cleared by the reticuloendothelial system. These reactions are detected most commonly in the blood bank when a subsequent patient sample reveals a positive alloantibody screen or a new alloantibody in a recently transfused recipient."
        },
        {
            "id": "InternalMed_Harrison_9022",
            "title": "InternalMed_Harrison",
            "content": "Febrile Nonhemolytic Transfusion Reaction The most frequent reaction associated with the transfusion of cellular blood components is a febrile nonhemolytic transfusion reaction (FNHTR). These reactions are characterized by chills and rigors and a \u22651\u00b0C rise in temperature. FNHTR is diagnosed when other causes of fever in the transfused patient are ruled out. Antibodies directed against donor leukocyte and HLA antigens may mediate these reactions; thus, multiply transfused patients and multiparous women are felt to be at increased risk. Although anti-HLA antibodies may be demonstrated in the recipient\u2019s serum, investigation is not routinely done because of the mild nature test result Positive test result Indirect Coombs test/ indirect antiglobulin test (Coombs reagent) the reb blood cell surface anti-RBC antibodies Blood sample from a patient with immune mediated haemolytic anaemia: antibodies are shown attached to antigens on the RBC surface. Recipient\u2019s serum is obtained, containing"
        },
        {
            "id": "Obstentrics_Williams_5474",
            "title": "Obstentrics_Williams",
            "content": "Of serious known risks, transfusion of an incompatible blood component may result in acute hemolysis. If severe, this can cause DIC, acute kidney injury, and death. Preventable errors responsible for most of such reactions frequently include mislabeling of a specimen or incorrectly transfusing a patient not slated for those products. The rate of such errors in the United States is estimated to be 1 in 14,000 units, but these events are likely underreported (Lerner, 2010). A transfusion reaction is characterized by fever, hypotension, tachycardia, dyspnea, chest or back pain, lushing, severe anxiety, and hemoglobinuria. Immediate supportive measures include stopping the transfusion, treating hypotension and hyperkalemia, provoking diuresis, and alkalinizing the urine."
        },
        {
            "id": "InternalMed_Harrison_9015",
            "title": "InternalMed_Harrison",
            "content": "Transfusion-transmitted viral infections are increasingly rare due to improved screening and testing. As the risk of viral infection is reduced, the relative risk of other reactions increases, such as hemolytic transfusion reactions and sepsis from bacterially contaminated components. Pretransfusion quality assurance improvements further increase the safety of transfusion therapy. Infections, like any adverse transfusion reaction, must be brought to the attention of the blood bank for appropriate studies (Table 138e-3). IMMUNE-MEDIATED REACTIONS Acute Hemolytic Transfusion Reactions Immune-mediated hemolysis occurs when the recipient has preformed antibodies that lyse donor erythrocytes. The ABO isoagglutinins are responsible for the majority of these reactions. However, alloantibodies directed against other RBC antigens, i.e., Rh, Kell, and Duffy, are responsible for more fatal hemolytic transfusion reactions."
        },
        {
            "id": "Surgery_Schwartz_855",
            "title": "Surgery_Schwartz",
            "content": "subsequent reactions.If an immediate hemolytic transfusion reaction is sus-pected, the transfusion should be stopped immediately, and a sample of the recipient\u2019s blood drawn and sent along with the suspected unit to the blood bank for comparison with the pretransfusion samples. Urine output should be monitored and adequate hydration maintained to prevent precipitation of hemo-globin within the tubules. Delayed hemolytic transfusion reac-tions do not usually require specific intervention.Transmission of Disease. Malaria, Chagas\u2019 disease, brucel-losis, and, very rarely, syphilis are among the diseases that have been transmitted by transfusion. Malaria can be transmitted by all blood components. The species most commonly implicated is Plasmodium malariae. The incubation period ranges from 8 to 100 days; the initial manifestations are shaking chills and spiking fever. Cytomegalovirus (CMV) infection resembling infectious mononucleosis also has occurred.Transmission of hepatitis C and"
        },
        {
            "id": "Pathology_Robbins_2987",
            "title": "Pathology_Robbins",
            "content": "U.S. hospitals each year. Thanks to improved screening of donors, blood products (packed red blood cells, platelets, and fresh-frozen plasma) are safer than ever before. Nevertheless, complications still occur. Most are minor and transient. The most common is referred to as a febrile nonhemolytic reaction, which takes the form of fever and chills, sometimes with mild dyspnea, within 6 hours of a transfusion of red cells or platelets. It is thought that these reactions are caused by inflammatory mediators derived from donor leukocytes. The frequency of these reactions increases with the storage age of the product and is decreased by measures that limit donor leukocyte contamination. Symptoms respond to anti-pyretics and are short-lived. Other transfusion reactions are uncommon or rare, but can have severe and sometimes fatal consequences, and therefore merit brief discussion."
        },
        {
            "id": "Pediatrics_Nelson_3296",
            "title": "Pediatrics_Nelson",
            "content": "Hgb, Hemoglobin; RBCs, red blood cells; vWF, von Willebrand factor. Acute hemolytic transfusion Acute shock, back pain, flushing, early fever, 1. Stop transfusion; return blood to bank with reaction (incidence of 1:250,000 to intravascular hemolysis, hemoglobinemia, fresh sample of patient\u2019s blood 1:1,000,000) hemoglobinuria (may be delayed 5\u201310 days and 2. Hydrate intravenously*; support blood less severe if anamnestic response is present) pressure, maintain high urine flow, alkalinize urine 3. Check for and correct electrolyte abnormalities (hyperkalemia) Allergic transfusion reaction (incidence of 1:100) Urticaria, pruritus, maculopapular rash, edema, respiratory distress, hypotension during or within 4 hours of transfusion; often because recipient has preformed antibodies against donor antigens, occasionally from passive infusion of antibodies from atopic donor Diphenhydramine \u00b1 hydrocortisone for acute management For future transfusions consider: 1."
        },
        {
            "id": "First_Aid_Step1_115",
            "title": "First_Aid_Step1",
            "content": "Tests: PPD for TB infection; patch test for contact dermatitis; Candida skin test for T cell immune function. 4T\u2019s: T cells, Transplant rejections, TB skin tests, Touching (contact dermatitis). Fourth (type) and last (delayed). Allergic/ Type I hypersensitivity Within minutes Allergies: urticaria, anaphylactic reaction against plasma to 2-3 hr (due to pruritus reaction proteins in transfused release of preformed Anaphylaxis: blood inflammatory wheezing, IgA-deficient individuals mediators in hypotension, should receive blood degranulating mast respiratory arrest, Donor plasma proteins, Host mast cell Acute Type II hypersensitivity During transfusion Fever, hypotension, hemolytic reaction or within 24 hr tachypnea, transfusion Typically causes (due to preformed tachycardia, reaction intravascular hemolysis antibodies) flank pain, Donor RBC with A and/ Host anti-A, anti-B IgG, incompatibility) (intravascular), jaundice (extravascular)"
        },
        {
            "id": "InternalMed_Harrison_9021",
            "title": "InternalMed_Harrison",
            "content": "No specific therapy is usually required, although additional RBC transfusions may be necessary. Delayed serologic transfusion reactions are similar to DHTR, because the DAT is positive and alloantibody is detected; however, RBC clearance is not increased."
        },
        {
            "id": "First_Aid_Step2_393",
            "title": "First_Aid_Step2",
            "content": "Diagnosed by clinical impression. Nonhemolytic febrile reactions: Stop the transfusion and control fever with acetaminophen. Rule out infection. Minor allergic reactions: Administer antihistamines. In the setting of a severe reaction, stop the transfusion and give epinephrine +/\u2013 steroids. Hemolytic transfusion reactions: Stop the transfusion immediately. Replace donor blood with normal saline; administer vigorous IV \ufb02 uids; and maintain good urine output (diuretics and pressors may be used to \u2191 renal blood \ufb02 ow). The porphyrias are a group of inherited disorders that include acute intermittent porphyria, porphyria cutanea tarda, and erythropoietic porphyria. Some porphyrias are autosomal dominant (e.g., acute intermittent porphyria) and others autosomal recessive (e.g., erythropoietic porphyria). All involve abnormalities of heme production that lead to an accumulation of porphyrins."
        },
        {
            "id": "Surgery_Schwartz_850",
            "title": "Surgery_Schwartz",
            "content": "12129/01/19 11:05 AM 122BASIC CONSIDERATIONSPART IHemolytic Reactions. Hemolytic reactions can be classified as either acute or delayed. Acute hemolytic reactions occur with the administration of ABO-incompatible blood and can be fatal in up to 6% of cases. Contributing factors include errors in the laboratory of a technical or clerical nature or the administra-tion of the wrong blood type. Immediate hemolytic reactions are characterized by intravascular destruction of red blood cells and consequent hemoglobinemia and hemoglobinuria. DIC can be initiated by antibody-antigen complexes activating factor XII and complement, leading to activation of the coagulation cas-cade. Finally, acute renal insufficiency results from the toxicity associated with free hemoglobin in the plasma, resulting in tubu-lar necrosis and precipitation of hemoglobin within the tubules.Delayed hemolytic transfusion reactions occur 2 to 10 days after transfusion and are characterized by extravascular"
        },
        {
            "id": "InternalMed_Harrison_9034",
            "title": "InternalMed_Harrison",
            "content": "Alloimmunization to antigens on leukocytes and platelets can result in refractoriness to platelet transfusions. Once alloimmunization has developed, HLA-compatible platelets from donors who share similar antigens with the recipient may be difficult to find. Hence, prudent transfusion practice is directed at preventing sensitization through the use of leukocyte-reduced cellular components, as well as limiting antigenic exposure by the judicious use of transfusions and use of SDAPs. NONIMMUNOLOGIC REACTIONS Fluid Overload Blood components are excellent volume expanders, and transfusion may quickly lead to transfusion-associated circulatory overload (TACO). Dyspnea with PaO2 <90% on room air, bilateral infiltrates on chest x-ray, and systolic hypertension are found with TACO. Brain natriuretic peptide (BNP) is often elevated (>1.5) compared with pretransfusion levels. Monitoring the rate and volume of the transfusion and using a diuretic can minimize this problem."
        },
        {
            "id": "Surgery_Schwartz_854",
            "title": "Surgery_Schwartz",
            "content": "haptoglobin levelPositive result on direct Coombs\u2019 test IgG mediatedIdentify patient\u2019s Ag to prevent recurrenceAb = antibody; Ag = antigen; CHF = congestive heart failure; DIC = disseminated intravascular coagulation; HLA = human leukocyte antigen; HNA = anti-human neutrophil antigen; IgG = immunoglobulin G; IgM = immunoglobulin M.Brunicardi_Ch04_p0103-p0130.indd 12229/01/19 11:05 AM 123HEMOSTASIS, SURGICAL BLEEDING, AND TRANSFUSIONCHAPTER 4transfused cells coated with patient antibody and is diagnostic. Delayed hemolytic transfusions may also be manifested by fever and recurrent anemia. Jaundice and decreased haptoglobin usu-ally occur, and low-grade hemoglobinemia and hemoglobinuria may be seen. The Coombs\u2019 test is usually positive, and the blood bank must identify the antigen to prevent subsequent reactions.If an immediate hemolytic transfusion reaction is sus-pected, the transfusion should be stopped immediately, and a sample of the recipient\u2019s blood drawn and sent along with"
        },
        {
            "id": "InternalMed_Harrison_9016",
            "title": "InternalMed_Harrison",
            "content": "Acute hemolytic reactions may present with hypotension, tachypnea, tachycardia, fever, chills, hemoglobinemia, hemoglobinuria, chest and/or flank pain, and discomfort at the infusion site. Monitoring Frequency, Episodes: Unit aInfectious agents rarely associated with transfusion, theoretically possible, or of unknown risk include West Nile virus, hepatitis A virus, parvovirus B19, Babesia microti and Babesia duncani (babesiosis), Borrelia burgdorferi (Lyme disease), Anaplasma phagocytophilum (human granulocytic ehrlichiosis), Trypanosoma cruzi (Chagas\u2019 disease), Treponema pallidum, and human herpesvirus-8. Abbreviations: FNHTR, febrile nonhemolytic transfusion reaction; HTLV, human T lymphotropic virus; RBC, red blood cell; TRALI, transfusion-related acute lung injury."
        },
        {
            "id": "Surgery_Schwartz_836",
            "title": "Surgery_Schwartz",
            "content": "blood bank immediately of urgent need for RBCs.O negative uncrossmatched (available immediately).As soon as possible, switch to O negative for females and O positive for males.Type-specific uncrossmatched (available in approximately 5\u201310 min).Completely crossmatched (available in approximately 40 min).2. A blood sample must be sent to blood bank for a type and cross.3. The Emergency Release of Blood form must be completed. If the blood type is not known and blood is needed immediately, O-negative RBCs should be issued.4. RBCs will be transfused in the standard fashion. All patients must be identified (name and number) prior to transfusion.5. Patients who are unstable or receive 1\u20132 RBCs and do not rapidly respond should be considered candidates for the massive transfusion (MT) guideline.B. Adult Massive Transfusion Guideline:1. The Massive Transfusion Guideline (MTG) should be initiated as soon as it is anticipated that a patient will require massive transfusion. The blood bank should"
        },
        {
            "id": "Histology_Ross_1342",
            "title": "Histology_Ross",
            "content": "If an individual is transfused with blood of an incompatible type, the recipient\u2019s antibodies will attack the donor erythrocytes, causing a hemolytic transfusion reaction, or destruction of the transfused erythrocytes. To prevent such be always cross-matched to the blood of a recipient. In this procedure, serum from the recipient is tested against the donor\u2019s erythrocytes. If there is no reaction to this cross-match test, then the donors\u2019 blood can be used for the transfusion."
        },
        {
            "id": "Surgery_Schwartz_803",
            "title": "Surgery_Schwartz",
            "content": "are of childbearing age.In emergency situations, universal donor type O-negative red blood cells and type AB plasma may be transfused to all recip-ients. Platelets do not require crossmatching. Due to a shortage of type AB plasma, low anti-B titer type A plasma has become widely adopted for emergency (uncrossmatched) transfusion.78 In the United States, 85% of individuals are type A or type O, mak-ing type A plasma compatible with the vast majority of poten-tial recipients. Uncrossmatched plasma is routinely transfused as part of platelet transfusions, with major transfusion reactions reported rarely,79 and type AB plasma currently carries a higher risk of TRALI compared to other plasma types.80 Many cen-ters have transitioned to low titer type A plasma for emergency transfusions, with no increase in adverse events.81 O negative and type-specific red blood cells are equally safe for emergency transfusion. In patients known to have clinically significant cold agglutinins, blood should"
        },
        {
            "id": "Pathology_Robbins_2988",
            "title": "Pathology_Robbins",
            "content": "Other transfusion reactions are uncommon or rare, but can have severe and sometimes fatal consequences, and therefore merit brief discussion. Severe, potentially fatal allergic reactions may occur when blood products containing certain antigens are given to previously sensitized recipients. These are most likely to occur in patients with IgA deficiency, which has a frequency of 1:300 to 1:500 people. The reaction is triggered by IgG antibodies that recognize IgA in the infused blood product. Fortunately, most patients with IgA deficiency do not develop such antibodies, and these severe reactions are rare, occurring in 1 in 20,000 to 1 in 50,000 transfusions. Urticarial allergic reactions may be triggered by the presence of an allergen in the donated blood product that is recognized by IgE antibodies in the recipient. These are more common, occurring in 1% to 3% of transfusions, but they are generally mild."
        },
        {
            "id": "InternalMed_Harrison_9025",
            "title": "InternalMed_Harrison",
            "content": "Allergic Reactions Urticarial reactions are related to plasma proteins found in transfused components. Mild reactions may be treated symptomatically by temporarily stopping the transfusion and administering antihistamines (diphenhydramine, 50 mg orally or intramuscularly). The transfusion may be completed after the signs and/or symptoms resolve. Patients with a history of allergic transfusion reaction should be premedicated with an antihistamine. Cellular components can be washed to remove residual plasma for the extremely sensitized patient."
        },
        {
            "id": "InternalMed_Harrison_9026",
            "title": "InternalMed_Harrison",
            "content": "Anaphylactic Reaction This severe reaction presents after transfusion of only a few milliliters of the blood component. Symptoms and signs include difficulty breathing, coughing, nausea and vomiting, hypotension, bronchospasm, loss of consciousness, respiratory arrest, and shock. Treatment includes stopping the transfusion, maintaining vascular access, and administering epinephrine (0.5\u20131 mL of 1:1000 dilution subcutaneously). Glucocorticoids may be required in severe cases. Patients who are IgA-deficient, <1% of the population, may be sensitized to this Ig class and are at risk for anaphylactic reactions associated with plasma transfusion. Individuals with severe IgA deficiency should therefore receive only IgA-deficient plasma and washed cellular blood components. Patients who have anaphylactic or repeated allergic reactions to blood components should be tested for IgA deficiency."
        },
        {
            "id": "Surgery_Schwartz_837",
            "title": "Surgery_Schwartz",
            "content": "Massive Transfusion Guideline:1. The Massive Transfusion Guideline (MTG) should be initiated as soon as it is anticipated that a patient will require massive transfusion. The blood bank should strive to deliver plasma, platelets, and RBCs in a 1:1:1 ratio. To be effective and minimize further dilutional coagulopathy, the 1:1:1 ratio must be initiated early, ideally with the first 2 units of transfused RBCs. Crystalloid infusion should be minimized.2. Once the MTG is activated, the blood bank will have 6 RBCs, 6 FFP, and a 6-pack of platelets packed in a cooler available for rapid transport. If 6 units of thawed FFP are not immediately available, the blood bank will issue units that are ready and notify appropriate personnel when the remainder is thawed. Every attempt should be made to obtain a 1:1:1 ratio of plasma:platelets:RBCs.3. Once initiated, the MT will continue until stopped by the attending physician. MT should be terminated once the patient is no longer actively"
        },
        {
            "id": "InternalMed_Harrison_8990",
            "title": "InternalMed_Harrison",
            "content": "Alloimmunization to leukocytes, platelets, and plasma proteins may also result in transfusion complications such as fevers and urticaria but generally does not cause hemolysis. Assay for these other alloantibodies is not routinely performed; however, they may be detected using special assays."
        },
        {
            "id": "Surgery_Schwartz_841",
            "title": "Surgery_Schwartz",
            "content": "and are fairly common (approximately 1% of all transfusions). Preformed cytokines in donated blood and recipi-ent antibodies reacting with donated antibodies are postulated eti-ologies. The incidence of febrile reactions can be greatly reduced by the use of leukocyte-reduced blood products. Pretreatment with acetaminophen reduces the severity of the reaction.Bacterial contamination of infused blood is rare. Gram-negative organisms, which are capable of growth at 4\u00b0C, are the most common cause. Most cases, however, are associated with the administration of platelets that are stored at 20\u00b0C or, even more commonly, with apheresis platelets stored at room tem-perature. Cases from FFP thawed in contaminated water baths have also been reported.150 Bacterial contamination can result in sepsis and death in up 25% of patients.151 Clinical manifesta-tions includes systemic signs such as fever and chills, tachycar-dia and hypotension, and gastrointestinal symptoms (abdominal cramps, vomiting,"
        }
    ],
    "scores": [
        0.03779304889870208,
        0.037002472893962746,
        0.036771918691964375,
        0.03561359407458174,
        0.035465385622494815,
        0.03530501529018475,
        0.03464355654464432,
        0.03462699650263973,
        0.03435269307570272,
        0.034322637477977286,
        0.033844718188016265,
        0.03346218319512402,
        0.033455509916631224,
        0.03125209730802788,
        0.03106403047971524,
        0.030637021677484107,
        0.030237883355732326,
        0.03008795135145395,
        0.029828129672082128,
        0.029810060358964108,
        0.029602120680082965,
        0.028637356200099898,
        0.02851773711141897,
        0.027886155440564712,
        0.027309408272454185,
        0.026447139886921073,
        0.026375404530744335,
        0.024752130994355376,
        0.024655627596804064,
        0.02387028384874264,
        0.02304738823195199,
        0.022938064114534702
    ],
    "execution_time": 21.67974352836609
}